{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:24:58Z","timestamp":1792790698227,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central finance-operation of public health emergency response mechanism of Chinese Center for Disease Control and Prevention","award":["102393220020010000017"],"award-info":[{"award-number":["102393220020010000017"]}],"id":[{"id":"https:\/\/ror.org\/04wktzw65","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01270-2","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:37:49Z","timestamp":1761824269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China"],"prefix":"10.1038","volume":"10","author":[{"given":"Dan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Rodewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zundong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"1270_CR1","first-page":"69","volume":"90","author":"World Health Organization","year":"2015","unstructured":"World Health Organization, Japanese encephalitis vaccines: WHO position paper-February 2015. Wkly Epidemiol. Rec. 90, 69\u201387 (2015).","journal-title":"Wkly Epidemiol. Rec."},{"key":"1270_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJMc2207004","volume":"387","author":"C Waller","year":"2022","unstructured":"Waller, C. et al. Japanese Encephalitis in Australia\u2014a sentinel case. N. Engl. J. Med. 387, 661\u2013662 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1270_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s44298-024-00025-5","volume":"2","author":"W Nguyen","year":"2024","unstructured":"Nguyen, W. et al. Characterisation of a Japanese Encephalitis virus genotype 4 isolate from the 2022 Australian outbreak. NPJ Viruses 2, 15 (2024).","journal-title":"NPJ Viruses"},{"key":"1270_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101509","volume":"62","author":"A Verma","year":"2024","unstructured":"Verma, A. et al. Nepal\u2019s Japanese encephalitis outbreak and the urgent need for updated vaccination guidelines. N. Microbes N. Infect. 62, 101509 (2024).","journal-title":"N. Microbes N. Infect."},{"key":"1270_CR5","doi-asserted-by":"publisher","unstructured":"Zhang, W., Xu, C., Nie, K. & Wang, H. Genotype 5 Japanese encephalitis virus\u2014old genotype, new threat. Zoonoseshttps:\/\/doi.org\/10.1056\/10.3201\/eid2605.190977(2022).","DOI":"10.1056\/10.3201\/eid2605.190977"},{"key":"1270_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3346\/jkms.2015.30.5.612","volume":"30","author":"HJ Kwon","year":"2015","unstructured":"Kwon, H. J. et al. The immunogenicity and safety of the live-attenuated SA 14-14-2 Japanese encephalitis vaccine given with a two-dose primary schedule in children. J. Korean Med. Sci. 30, 612\u2013616 (2015).","journal-title":"J. Korean Med. Sci."},{"key":"1270_CR7","doi-asserted-by":"crossref","unstructured":"Capeding, M. R. et al. Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9\u201312 months of age in the Philippines: a non-inferiority Phase 4 randomized clinical trial. Vaccine. 6, 100074 (2020).","DOI":"10.1016\/j.jvacx.2020.100074"},{"key":"1270_CR8","doi-asserted-by":"publisher","first-page":"e0005866","DOI":"10.1371\/journal.pntd.0005866","volume":"11","author":"SR Upreti","year":"2017","unstructured":"Upreti, S. R. et al. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal. PLoS Negl. Trop. Dis. 11, e0005866 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1270_CR9","unstructured":"Department of Health Services Family Welfare Division, Ministry of Health and Population of Government of Nepal. Acute Encephalitis Syndrome Japanese Encephalitis Surveillance Manual. https:\/\/fwd.gov.np\/article\/aes-je-surveillance-e-manual#iframe (2025)."},{"key":"1270_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3345\/cep.2020.01984","volume":"65","author":"BO Kwak","year":"2022","unstructured":"Kwak, B. O., Hong, Y. J. & Kim, D. H. Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea. Clin. Exp. Pediatr. 65, 108\u2013114 (2022).","journal-title":"Clin. Exp. Pediatr."},{"key":"1270_CR11","unstructured":"Korea Disease Control and Prevention Agency. National Immunization Program for children https:\/\/www.kdca.go.kr\/contents.es?mid=a30333000000 (2025)."},{"key":"1270_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4038\/cmj.v61i3.8344","volume":"61","author":"K Sanchayan","year":"2016","unstructured":"Sanchayan, K. et al. Safety of live attenuated Japanese encephalitis vaccine given at the age of 9 months in National Immunisation Programme of Sri Lanka. Ceylon Med J. 61, 99\u2013105 (2016).","journal-title":"Ceylon Med J."},{"key":"1270_CR13","unstructured":"World Health Organization Regional office for South-East Asia, SRI LANKA FACTSHEET 2023. https:\/\/iris.who.int\/bitstream\/handle\/10665\/375315\/Sri%20Lanka-EPI-Factsheet-2023.pdf?sequence=1 (2023)."},{"key":"1270_CR14","doi-asserted-by":"publisher","unstructured":"Hattasingh, W. et al. Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children. Hum. Vacc. Immunother. https:\/\/doi.org\/10.1080\/21645515.2022.2028513 (2022).","DOI":"10.1080\/21645515.2022.2028513"},{"key":"1270_CR15","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/21645515.2017.1414763","volume":"14","author":"P Chanthavanich","year":"2018","unstructured":"Chanthavanich, P. et al. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children. Hum. Vaccin. Immunother. 14, 900\u2013905 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1270_CR16","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.vaccine.2016.07.029","volume":"34","author":"JP Cramer","year":"2016","unstructured":"Cramer, J. P. et al. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: open-label, uncontrolled, multi-center, phase 4 study. Vaccine 34, 4579\u20134585 (2016).","journal-title":"Vaccine"},{"key":"1270_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00338-z","volume":"6","author":"KS Vannice","year":"2021","unstructured":"Vannice, K. S. et al. The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control. NPJ Vaccines 6, 82 (2021).","journal-title":"NPJ Vaccines"},{"key":"1270_CR18","first-page":"1","volume":"26","author":"Yin Ning Guijun","year":"2020","unstructured":"Ning Guijun, Y. in et al. Epidemiological characteristics of Japanese encephalitis in China, 2011-2013. Chin. J. Vaccines Immun. 26, 1\u20134 (2020). Wu Dan.","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR19","first-page":"160","volume":"30","author":"Yin Wu Dan","year":"2024","unstructured":"Wu Dan, Y. in et al. Epidemiology of Japanese encephalitis in China, 2014-2018. Chin. J. Vaccines Immun. 30, 160\u2013164 (2024).","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR20","first-page":"160","volume":"30","author":"Yan Tingting","year":"2024","unstructured":"Tingting, Y. an et al. Epidemiology of Japanese encephalitis in China, 2019-2022. Chin. J. Vaccines Immun. 30, 160\u2013164 (2024).","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4269\/ajtmh.23-0036","volume":"108","author":"SL Hills","year":"2023","unstructured":"Hills, S. L., Netravathi, M. & Solomon, T. Japanese Encephalitis among Adults: A Review. Am. J. Tropical Med. Hyg. 108, 860\u2013864 (2023).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"1270_CR22","doi-asserted-by":"crossref","unstructured":"Misan, A., Lambert, S. B., Phung, H. & Young, M. K. Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak. Epidemiol Infect. e17610.1017\/S0950268824001730 (2024).","DOI":"10.1017\/S0950268824001730"},{"key":"1270_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3201\/eid2210.160288","volume":"22","author":"JS Sunwoo","year":"2016","unstructured":"Sunwoo, J. S., Jung, K. H., Lee, S. T., Lee, S. K. & Chu, K. Reemergence of Japanese Encephalitis in South Korea, 2010\u20132015. Emerg. Infect. Dis. 22, 1841\u20131843 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"1270_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijid.2016.05.008","volume":"48","author":"DW Lee","year":"2016","unstructured":"Lee, D. W. et al. Epidemiology of Japanese encephalitis in South Korea, 2007\u20132010 (vol 16, pg e448, 2012). Int. J. Infect. Dis. 48, 84\u201384 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"1270_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.7883\/yoken.JJID.2004.63","volume":"57","author":"R Ayukawa","year":"2004","unstructured":"Ayukawa, R. et al. An unexpected outbreak of Japanese encephalitis in the Chugoku district of Japan, 2002. Jpn J. Infect. Dis. 57, 63\u201366 (2004).","journal-title":"Jpn J. Infect. Dis."},{"key":"1270_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jinf.2017.09.018","volume":"76","author":"K Kanagasabai","year":"2018","unstructured":"Kanagasabai, K. et al. Epidemiology of Japanese Encephalitis in India: analysis of laboratory surveillance data, 2014-2017. J. Infect. 76, 317\u2013320 (2018).","journal-title":"J. Infect."},{"key":"1270_CR27","first-page":"270","volume":"13","author":"Z Yin","year":"2007","unstructured":"Yin, Z. et al. Investigation and analysis on the Japanese B encephalitis epidemic in yuncheng prefecture, Shanxi Province. Chin. J. Vaccines Immun. 13, 270\u2013273 (2007).","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR28","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1111\/tbed.13945","volume":"68","author":"D Wu","year":"2021","unstructured":"Wu, D. et al. Emergence of Japanese encephalitis among adults 40 years of age or older in northern China: epidemiological and clinical characteristics. Transbound. Emerg. Dis. 68, 3415\u20133423 (2021).","journal-title":"Transbound. Emerg. Dis."},{"key":"1270_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28782","volume":"95","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: a retrospective epidemiological study. J. Med. Virol. 95, e28782 (2023).","journal-title":"J. Med. Virol."},{"key":"1270_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1056\/NEJMc1916977","volume":"12","author":"GLH Wang","year":"2020","unstructured":"Wang, G. L. H. et al. Guillain-Barr\u00e9 syndrome associated with JEV infection. N. Engl. J. Med. 12, 1188\u20131190 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1270_CR31","doi-asserted-by":"publisher","first-page":"e0008312","DOI":"10.1371\/journal.pntd.0008312","volume":"14","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. An outbreak of Japanese encephalitis caused by genotype Ib Japanese encephalitis virus in China, 2018: a laboratory and field investigation. PLoS Negl. Trop. Dis. 14, e0008312 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1270_CR32","first-page":"646","volume":"25","author":"CT Liu","year":"2019","unstructured":"Liu, C. T. et al. Neutralizing antibody levels against Japanese encephalitis virus among healthy people in ethnic minority areas of Guizhou province, 2017. Chin. J. Vaccines Immun. 25, 646\u2013649 (2019).","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR33","first-page":"634","volume":"23","author":"SY Luo","year":"2017","unstructured":"Luo, S. Y. et al. A serological survey for Japanese encephalitis antibodies among a healthy population in Yiwu city of Zhejiang province, 2015-2016. Chin. J. Vaccines Immun. 23, 634\u2013637 (2017).","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR34","first-page":"567","volume":"36","author":"C Lou","year":"2020","unstructured":"Lou, C. et al. Japanese encephalitis antibody surveillance in Yanqing district of Beijing, 2017. J. Mod. Med. Health 36, 567\u2013568 (2020).","journal-title":"J. Mod. Med. Health"},{"key":"1270_CR35","unstructured":"Haixia, W. & Qiyong, L. The impact of global climate change on vector borne infectious diseases. In Proceedings of the First Climate Change and Health Forum of the Chinese Center for Disease Control and Prevention. 50\u201353 (2010)."},{"key":"1270_CR36","first-page":"182","volume":"34","author":"L Hongyun","year":"2023","unstructured":"Hongyun, L. et al. Influence of vector invasion driven by climate change and economic globalization on human health. Chin. J. Vector Biol. Control 34, 182\u2013188 (2023).","journal-title":"Chin. J. Vector Biol. Control"},{"key":"1270_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4103\/ijmr.IJMR_712_15","volume":"144","author":"SA Khan","year":"2016","unstructured":"Khan, S. A. et al. Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults. Indian J. Med. Res. 144, 886\u2013892 (2016).","journal-title":"Indian J. Med. Res."},{"key":"1270_CR38","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1080\/21645515.2019.1642056","volume":"15","author":"MA Carlock","year":"2019","unstructured":"Carlock, M. A. et al. Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses. Hum. Vaccin Immunother. 15, 2030\u20132043 (2019).","journal-title":"Hum. Vaccin Immunother."},{"key":"1270_CR39","first-page":"661","volume":"29","author":"Z Ying","year":"2023","unstructured":"Ying, Z. et al. Immunogenicity of one dose of Japanese encephalitis attenuated live vaccine among 2-70-year.olds in north Ningxia Hui Autonomous Region. Chin. J. Vaccines Immun. 29, 661\u2013664 (2023).","journal-title":"Chin. J. Vaccines Immun."},{"key":"1270_CR40","doi-asserted-by":"publisher","unstructured":"Turtle, L. et al. Cellular immune responses to live attenuated Japanese encephalitis (JE) vaccine sa14-14-2 in adults in a JE\/dengue co-endemic area. PLoS Neglect Trop. D. https:\/\/doi.org\/10.1371\/journal.pntd.0005263(2017).","DOI":"10.1371\/journal.pntd.0005263"},{"key":"1270_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/jtm.12210","volume":"22","author":"T Jelinek","year":"2015","unstructured":"Jelinek, T. et al. Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: a phase III, multicenter, observer-blind study. J. Travel Med. 22, 225\u2013231 (2015).","journal-title":"J. Travel Med."},{"key":"1270_CR42","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1016\/j.vaccine.2021.10.050","volume":"39","author":"CMC Rodrigues","year":"2021","unstructured":"Rodrigues, C. M. C. SAP. The influence of interval between doses on response to vaccines. Vaccine 39, 7123\u20137127 (2021).","journal-title":"Vaccine"},{"key":"1270_CR43","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/21645515.2017.1414763","volume":"14","author":"P Chanthavanich","year":"2018","unstructured":"Chanthavanich, P. et al. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children. Hum. Vaccin Immunother. 14, 900\u2013905 (2018).","journal-title":"Hum. Vaccin Immunother."},{"key":"1270_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tmaid.2018.03.003","volume":"22","author":"T Jelinek","year":"2018","unstructured":"Jelinek, T. et al. Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO\u00ae, JESPECT\u00ae) in a pediatric population in JE non-endemic countries: an uncontrolled, open-label phase 3 study. Travel Med. Infect. Dis. 22, 18\u201324 (2018).","journal-title":"Travel Med. Infect. Dis."},{"key":"1270_CR45","first-page":"S195","volume":"94","author":"T Chotpitayasunondh","year":"2011","unstructured":"Chotpitayasunondh, T. et al. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand. J. Med. Assoc. Thai 94, S195\u2013S203 (2011).","journal-title":"J. Med. Assoc. Thai"},{"key":"1270_CR46","doi-asserted-by":"crossref","unstructured":"Dooling, K. L. et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb. Mortal Wkly Rep. 67, 103\u2013108 (2018).","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"1270_CR47","unstructured":"World Health Organization. Manual for the laboratory diagnosis of Japanese encephalitis virus infection. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/vpd_surveillance\/lab_networks\/manual-lab-diagnosis-je.pdf?sfvrsn=e2b62a35_4 (2007)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01270-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01270-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01270-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:37:53Z","timestamp":1761824273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01270-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01270-2","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all individuals who participated in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"222"}}